No material event; stock likely to trade on broader biotech sentiment and M&A speculation. Watch for any definitive acquisition agreement or pipeline update as the next catalyst.
Price Chart
Executive Summary
Instil Bio reported Q1 2026 GAAP EPS of -$0.62, a slight miss vs consensus -$0.59, but as a pre-revenue biotech the absolute variance is immaterial. Cash burn remains low at $1.6M during the quarter, with $74.7M cash expected to fund operations beyond 2027. The company is actively evaluating M&A opportunities but provided no specific updates.
Key Financial Metrics
Key Facts
- GAAP net loss per share of $0.62 for Q1 2026, compared to $4.32 in Q1 2025
- Cash, equivalents, restricted cash and marketable securities of $74.7M as of March 31, 2026
- R&D expenses fell to $0.7M from $5.4M; G&A to $5.3M from $9.1M year-over-year
- Restructuring charges of $1.0M, down from $16.1M in prior-year quarter
- Gain on contract termination of $1.6M offset operating loss
Financial Impact
EPS miss of $0.03 vs consensus; cash decreased $1.6M from year-end 2025
Risk Factors
- No revenue-generating products; reliance on M&A for growth
- Cash burn may accelerate if a transaction is pursued
- Dilution risk if stock is used to finance acquisitions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001789769-26-000044 |
| Document: til-20260515.htm | 0001789769-26-000044 |
| Document: 0001789769-26-000044-index-headers.html | 0001789769-26-000044 |
| Document: 0001789769-26-000044-index.html | 0001789769-26-000044 |
| Document: 0001789769-26-000044.txt | 0001789769-26-000044 |
| 8-K Data (Synthetic) | 0001789769-26-000044 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | Press Release | $7.38 $7.45 | ▲ +0.95% | ▲ +2.94% | $7.34 (−0.54%) |
Aug 13, 2026 7w ago | 8-K | $7.38 $7.45 | ▲ +0.95% | ▲ +2.94% | $7.34 (−0.54%) |
May 15, 2026 20w ago | 8-K | $8.07 $7.92 | ▼ −1.86% | ▼ −3.98% | $7.34 (−9.05%) |
May 15, 2026 20w ago | Press Release | $8.07 $7.92 | ▼ −1.86% | ▼ −3.98% | $7.34 (−9.05%) |
Apr 24, 2026 22w ago | DEFA14A | $8.13 $8.12 | ▼ −0.12% | ▼ −5.08% | $7.34 (−9.72%) |
Apr 3, 2026 26w ago | 8-K | $8.46 $7.84 | ▼ −7.33% | ▼ −16.31% | $7.34 (−13.24%) |
Mar 27, 2026 27w ago | Press Release | $7.79 $8.13 | ▲ +4.36% | ▼ −8.38% | $7.34 (−5.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access